Model unable to identify focal therapy candidatesThe development of a model for identifying prostate cancer patients who may be appropriate candidates for hemi-ablative focal therapy remains a work in progress for researchers at Memorial Sloan Kettering Cancer Center.
In this issue
Prostate MRI has value, but results are not ‘gospel’Magnetic resonance imaging (MRI) of the prostate may be used in many clinical scenarios, including primary screening, active surveillance, and in patients with a previous negative biopsy and rising PSA. In this interview, Scott Eggener, MD, explains whether MRI is warranted in each of these situations and the benefits and challenges this technology presents. How to choose the best retirement savings planThere are several options for saving for retirement, but first develop a good understanding of how these retirement accounts work to get the most out of your savings. Prostate MRI-Bx may ID partial gland ablation candidates September 01, 2017By Cheryl Guttman KraderInformation from magnetic resonance imaging and systematic biopsy may be used to identify candidates for partial gland ablation among men with recurrent localized prostate cancer after radiation therapy, researchers from Memorial Sloan Kettering Cancer Center reported at the AUA annual meeting in Boston. Gout patients at 60% greater risk for stone disease September 04, 2017By Lisette HiltonMen and women with gout are at 60% greater risk for nephrolithiasis than adults without gout, according to a study looking at not only the chronic kidney condition’s incidence but also potential risk factors for first-time nephrolithiasis in people with and without gout.
Prostate Ca study reveals more evidence of racial disparity September 06, 2017By Cheryl Guttman KraderResults of a study examining receipt of definitive therapy for intermediate/high-risk localized prostate cancer provide further evidence of racial disparity in prostate cancer favoring Caucasian men over African-American men.
Quality initiative could reduce unnecessary PCa bone scans September 06, 2017By Andrew BowserOne gentle “nudge” may be all it takes to start reducing the number of unnecessary bone scans ordered for asymptomatic men with low-risk prostate cancer, results of a recent quality improvement intervention suggest.
5-ARI use does not raise erectile dysfunction risk September 01, 2017By Wayne KuznarThe risk of erectile dysfunction is not increased with the use of a 5-alpha-reductase inhibitor compared with an alpha-blocker for the treatment of BPH.
Water vapor ablation yields positive results at 2 years September 08, 2017By Aine CrytsTreatment of lower urinary tract symptoms/BPH with convective water vapor ablation (Rezum System) appears to provide significant improvement on two key outcome measures versus medical therapy at up to 2 years, according to a study presented at the AUA annual meeting in Boston. Fusion Bx-guided HIFU shows promise in localized PCa September 01, 2017By Cheryl Guttman KraderEarly follow-up of men with localized prostate cancer treated with novel technology that integrates fusion biopsy findings to guide high-intensity focused ultrasound (HIFU [Focal One]) shows the technique has promise for minimizing post-treatment morbidity while providing good cancer control, Italian researchers reported at the AUA annual meeting in Boston. Waterjet ablation confers advantages over TURP September 12, 2017By Cheryl Guttman KraderHeat-free high-velocity waterjet ablation (Aquablation) for BPH performed with an image-guided robot-assisted platform (AquaBeam System) met its primary safety and efficacy endpoints in a phase III study.
Urologists no longer primary initiator of tamsulosin September 01, 2017By Wayne KuznarUrologists are no longer the primary initiators of tamsulosin (Flomax) therapy in the United States, suggests an analysis of pharmaceutical claims from more than 50 private health plans. Investigational BCG-refractory NMIBC Tx shows promise September 13, 2017By Cheryl Guttman Krader“rAd-IFNα gene therapy is a breakthrough opportunity for effective local management of BCG-unresponsive NMIBC,” says researcher Colin P. N. Dinney, MD.
Bladder Ca photothermal treatment yields encouraging results September 13, 2017By Andrew BowserPhotothermal treatment with epidermal growth factor receptor-directed gold nanorods results in considerable antineoplastic activity in an early study of bladder cancer.
APRNs, PAs can help achieve the ideal practice setting September 19, 2017By Amy Hull MSN WHNP-BC"Patient care can continue in the office while the urologist is in the OR; APRNs and PAs can serve as a conduit for readying patients for surgery, and these providers can evaluate for potential complications post-surgery," writes SUNA's Amy Hull, MSN, WHNP-BC. Is your ideal practice fit within reach? September 19, 2017By Lisette HiltonDeciding on whether to go into (or switch to) private practice, academic, or an employed model means weighing potential pros and cons of each setting and looking in the mirror at character traits, likes, and dislikes that would make one setting more suitable than another. How do ureteroscope types compare ergonomically? September 25, 2017By Cheryl Guttman KraderFindings of a study investigating biomechanical stresses on the urologist while performing flexible ureteroscopy indicate that reusable and single-use digital ureteroscopes have a more favorable ergonomic profile than a reusable fiberoptic instrument.
Episode costs for ambulatory stone surgery vary widely September 25, 2017By Cheryl Guttman KraderA study analyzing variation in spending for patients undergoing ureteroscopy or shock wave lithotripsy for urinary stone disease is a step towards helping urologists understand cost reduction opportunities.
ADT plus salvage RT lowers PCa metastases, raises survival September 01, 2017By Badar M. Mian MDA recent review of two phase III randomized controlled trials demonstrated that addition of androgen deprivation therapy to salvage pelvic radiation therapy for prostate cancer recurrence after radical prostatectomy reduces the risk of metastases and improves overall survival.
How emotional intelligence can enhance the provider-patient relationship“Fostering emotional intelligence among providers supports the provision of high-quality and compassionate care,” writes Adele M. Caruso, DNP, CRNP.
2018 ICD-10-CM codes, guidelines: What you need to knowThis article provides an overview of the new 2018 ICD-10-CM codes, revisions, and deletions that are relevant to urology practice.